Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Länsförsäkringar Skåne’s real estate company Länshem Skåne in connection with an acquisition from Wihlborgs
Mandate

Vinge advises Länsförsäkringar Skåne’s real estate company Länshem Skåne in connection with an acquisition from Wihlborgs

August 23, 2019 M&A

Vinge has advised Länsförsäkringar Skåne’s real estate company Länshem Skåne in connection with the acquisition from Wihlborgs of the property Gängtappen 1 i Dockan in Malmö for SEK 720 million.

Gängtappen was built in 1958 as a head office for Kockums and has a lettable area of 14,400 square metres and is fully rented. Länsförsäkringar Skåne is the largest tenant. Completion will occur on 1 December 2019. 

Vinge’s team consisted of Henrik Ossborn together with, among others, associates Fredrik Christiansson, Jessica Salomonsson and Jack Bengtsson. Mathias Lindquist provided environmental law advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026